| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.039 | 0.4 |